Introduction
In the mammalian small intestine the driving force for fl uid absorption is the active transport of sodium and chloride, which may be electrically silent [1] or which may involve electrogenic sodium transport [2] . The primary mechanism responsible for the transepithelial sodium transport in the small intestine is the basolateral Na + ,K + -ATPase [3] of both absorptive and secretory cell types [4, 5] . The transepithelial transport of other solutes and electrolytes such as glucose, amino acids, chloride and bicarbonate is indirectly coupled to sodium transport [4] .
The basal activity of the intestinal Na + ,K + -ATPase can be infl uenced or modulated by different factors including dopamine. In the intestine, the dopaminergic system has been characterized as a local non-neuronal system constituted by epithelial cells of intestinal mucosa rich in aromatic L -amino acid decarboxylase (AADC), the enzyme responsible for the synthesis of dopamine from circulating or luminal L -3,4-dihydroxyphenylalanine ( L -Dopa) [6] . Dopamine is particularly abundant in the mucosal
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Abstract

Background:
The occurrence of complementary functions in sodium transport between the intestine and the kidney was suggested to occur when the renal function is immature or compromised and jejunal dopamine has been implicated in this renal-intestinal cross-talk. The jejunal sodium transport was not previously evaluated in the nephrotic syndrome. Methods: We examined the jejunal Na + ,K + -ATPase activity and the role of dopamine in puromycin aminonucleoside (PAN) and HgCl 2 -induced nephrotic syndrome rat models. Results: In both nephrotic syndrome rat models, the jejunal Na + ,K + -ATPase activity was reduced during greatest sodium retention and ascites accumulation (PAN nephrosis, day 7; HgCl 2 nephrosis, day 14), whereas during enhanced sodium excretion and ascites mobilization the jejunal Na + ,K + -ATPase activity was increased in HgCl 2 nephrosis (day 21) and was similar to controls in PAN nephrosis (day 14). In both PAN-and HgCl 2 -induced nephrosis, the jejunal aromatic L -amino acid decarboxylase (AADC) activity, the enzyme responsible for the synthesis of jejunal dopamine, did not differ from controls. In addition, the jejunal Na + ,K + -ATPase activity was not sensitive to inhi-cell layer [7, 8] and the highest AADC activity is located in the jejunum [9] , where dopamine activates dopamine receptors as a paracrine/autocrine substance [6] . Although the small intestine is responsible for most of the absorption of nutrients, water and electrolytes [10] , under normal circumstances wide variations in salt intake are translated into parallel changes in renal salt excretion, so that the extra-cellular volume is maintained within narrow limits [11] . This suggests that the relative importance of the intestinal sodium absorption on the control of extracellular volume may assume particular relevance when the renal handling of sodium is compromised. Accordingly, wide variations in sodium intake did not change the jejunal Na + ,K + -ATPase activity or the jejunal dopamine production in adult rats with mature and well-functioning kidneys whereas during early postnatal life when the kidney has a limited capacity to regulate fl uid and electrolytes metabolism a high sodium intake was accompanied by a decreased jejunal Na + ,K + -ATPase activity which was sensitive to inhibition by dopamine [12] . These results suggest the occurrence of complementary functions between the intestine and the kidney during development. Interestingly, it has been recently reported a signifi cant reduction in jejunal Na + ,K + -ATPase activity with recovered sensitivity to inhibition by dopamine in rats submitted to uninephrectomy [13] . This further reinforces the view that the infl uence of jejunal Na + ,K + -ATPase activity on sodium homeostasis may assume particular importance when the renal function is compromised.
Nephrotic syndromes may develop in human patients as a result of primary diseases as well as in laboratory animals in response to toxic substances such as puromycin aminonucleoside (PAN) and mercury chloride (HgCl 2 ) [14] . The features of the nephrotic syndrome in both man and experimental rat models are massive proteinuria and development of edema and extra-cellular volume expansion secondary to abnormal renal sodium retention. Although the exact mechanisms involved in the enhanced sodium reabsorption in the nephrotic syndrome still remain to be fully elucidated, most of the available evidences implicate a primary renal sodium handling abnormality in the cortical collecting ducts [15] .
Because the extracellular volume expansion in the nephrotic syndrome is related to disruption of the normal renal sodium handling mechanisms, we found it was worthwhile to study the jejunal Na + ,K + -ATPase and dopaminergic activities in both PAN nephrosis and HgCl 2 -induced membranous nephropathy.
Materials and Methods
In vivo Studies
PAN Nephrosis
Normotensive male Sprague-Dawley rats (Harlan, Barcelona, Spain), weighing 200-220 g, were selected after a 7-day period of stabilization and adaptation to blood pressure measurements. The animals received a single intraperitoneal injection of 10 ml ؒ kg BW -1 of PAN (150 mg ؒ kg BW -1 ) or the vehicle (NaCl 0.9%) on the day 0.
HgCl 2 Nephrosis
Normotensive male Brown-Norway rats (Harlan), weighing 150-160 g, were selected after a 7-day period of stabilization and adaptation to blood pressure measurements. The animals received subcutaneous injections of 1 ml ؒ kg BW -1 of HgCl 2 (1 mg ؒ kg BW -1 ) or the vehicle (NaCl 0.9%) on days 0, 2, 4, 7, 9 and 11.
The animals were kept under controlled environmental conditions (12: 12 h light/dark cycle and room temperature 22 8 2 ° C); fl uid intake and food consumption were monitored daily throughout the study. All animals had free access to tap water. The PANtreated and HgCl 2 -treated animals were fed ad libitum throughout the study with ordinary rat chow (Panlab, Barcelona, Spain) containing 1.9 g ؒ kg -1 of sodium. In order to achieve the same daily sodium intake between groups, the vehicle-treated rats had only access to the mean daily rat chow intake of the respective nephrotic animals. The rats were kept in metabolic cages (Techniplast, Buguggiate, VA, Italy) for the collection of 24-hour urine. Blood pressure (systolic and diastolic) was measured weekly throughout the study in conscious restrained animals using a photoelectric tailcuff pulse detector (LE 5000, Letica, Barcelona, Spain). Four determinations were made each time and the means were used for further calculation. On the days of sacrifi ce (PAN, days 7 and 14; HgCl 2 , days 7, 14 and 21), the animals were anesthetized with pentobarbital sodium (50 mg ؒ kg BW -1 i.p.). The ascites weight was determined through moistening and weighing an absorbent paper. Blood was collected from the heart in tubes containing lithium/ heparin for later determination of sodium and creatinine. Segments of jejunum with ϳ 10 cm in length were removed, opened longitudinally with fi ne scissors and rinsed free from blood and intestinal contents with cold saline. One segment was used for the assay of Na + ,K + -ATPase activity in jejunal epithelial cells. On a different segment, the jejunal mucosa was removed with a scalpel. Fragments of jejunal mucosa were used for later determination of AADC activity, whereas other fragments weighing around 200 mg were placed in vials containing 1 ml of 0.2 M perchloric acid and stored at -80 ° C until quantifi cation of catecholamines by HPLC with electrochemical detection.
In vitro Studies AADC Activity AADC activity was determined in homogenates of jejunal mucosa, using L -Dopa (0.1-10 m M ) as substrate [16, 17] . The assay of dopamine was performed by HPLC with electrochemical detection. The protein content in cell suspension (1.5 mg ؒ ml -1 ) was determined by the method of Bradford [18] . trichloroacetic acid. The samples were centrifuged (4,000 rpm) and liberated P i in the supernatant was measured as the result of ATPase activity. The assay of P i was performed by spectrophotometry. Ouabain-sensitive ATPase activity is expressed as nanomoles of P i per miligram of protein per minute and determined as the difference between total and ouabain-resistant ATPase. The protein content in cell suspension (1.1 mg ؒ ml -1 ) was determined by the method described by Bradford [18] using bovine serum albumin as standard. For both Sprague-Dawley and Brown-Norway rat strains, the relationship between the incubation time and Na 
Assay of Catecholamines
The assays of dopamine and L -Dopa in urine, norepinephrine in jejunal mucosa and dopamine in samples from AADC studies were performed by HPLC with electrochemical detection, as previously described [21] . In our laboratory, the lower limit of detection of dopamine ranged from 350 to 1,000 fmol.
Plasma and Urine Ionogram and Biochemistry
Ion-selective electrodes performed the quantifi cations of sodium. Creatinine was measured by the Jaffé method. Total proteins were determined by a colorimetric test, the biuret reaction. The assays were performed through Cobas Mira Plus analyser (ABX Diagnostics, Switzerland). Creatinine clearance was calculated using 24-hour urine creatinine excretion. Fractional excretion of sodium (FE Na+ ) was calculated as previously reported [16] . Sodium balance was determined subtracting the absolute daily urinary sodium excretion (mmol ؒ 24 h -ATPase enzymatic assay were calculated from nonlinear regression analysis using GraphPad Prism statistics software package [22] and compared by one-way ANOVA followed by Student's t test for unpaired comparisons. p ! 0.05 was assumed to denote a signifi cant difference.
Results
PAN Nephrosis
The PAN-treated rats developed severe proteinuria on day 4 and beyond reaching a plateau on day 8, whereas the renal protein excretion was minimal in control animals throughout the study ( fi g. 1 ). In parallel, the PANtreated rats showed a marked decrease in urinary sodium excretion compared with control animals from days 2 to 8, followed by an increase in the urinary excretion of sodium from days 12 to 14 ( fi g. 1 ). On day 7, the PANtreated rats exhibited a positive sodium balance and a reduced FE Na+ accompanied by marked ascites accumulation, whereas on day 14 the PAN-treated rats presented a negative sodium balance and an increased FE Na+ accompanied by ascites of much smaller magnitude ( table  1 ) . The creatinine clearance was lower in PAN-treated than in control rats either on day 7 or on day 14 ( -ATPase and dopaminergic activities were evaluated in PAN-treated rats in conditions of greatest sodium retention and ascites accumulation (day 7), as well as during enhanced sodium excretion and negative sodium balance (day 14) ( fi g. 1 ; table 1 ).
The kinetic parameters of Na The activity of AADC in homogenates of jejunal mucosa from PAN-treated and control rats is depicted in table 2 . As can be observed, the V max and K m values for AADC activity in the jejunal mucosa did not differ between PAN-treated and control rats, either on day 7 or day 14 ( table 2 ). In addition, dopamine (1 M ) did not change the jejunal Na + ,K + -ATPase activity in either PAN-treated or control rats on days 7 and 14 ( table 3 ) .
In PAN-treated rats the urinary levels of dopamine were signifi cantly reduced on days 7 and 14 ( table 4 ) . By contrast, the urinary excretion of the dopamine precursor, L -Dopa, did not differ between PAN-treated and control animals ( table 4 ). This resulted in markedly reduced urinary dopamine/ L -Dopa ratios in PAN-treated rats throughout the study ( The tissue levels of norepinephrine in the jejunal mucosa were increased in PAN-treated rats on day 7, whereas on day 14 the jejunal tissue levels of norepinephrine were similar between PAN-treated and control rats ( table 5 ).
HgCl 2 Nephrosis
In HgCl 2 -treated rats, the proteinuria remained undetectable or very low until day 9 and increased from day 11 and beyond reaching the highest levels between days 15 and 17 ( fi g. 3 ). The urinary sodium excretion was decreased in HgCl 2 -treated rats compared with control animals from days 3 to 14 followed by an increase in urinary sodium excretion from days 17 to 21 ( fi g. 3 ). Consequently, the HgCl 2 -treated rats presented a positive sodium balance on both days 7 and 14, this being statistically signifi cant on Based on these fi ndings the jejunal Na + ,K + -ATPase and dopaminergic activities were evaluated in HgCl 2 -treated rats in conditions of sodium retention and negligible proteinuria (day 7), during greatest sodium retention and increased proteinuria (day 14) as well as during enhanced sodium excretion and negative sodium balance (day 21) ( fi g. 3 ; table 6 ).
The kinetic parameters of Na fi g. 4 ) .
The activity of AADC in homogenates of jejunal mucosa from HgCl 2 -treated and control rats is depicted in table 7 . As can be observed, the V max and K m values for AADC activity in the jejunal mucosa did not differ between HgCl 2 -treated and control rats on days 7, 14 or 21 ( table 7 ) . In addition, dopamine (1 M ) did not change the Na + ,K + -ATPase activity in jejunal epithelial cells from both HgCl 2 -treated and control rats throughout the study ( table 8 ) .
In HgCl 2 -treated rats the urinary levels of dopamine were signifi cantly decreased on days 7, 14 and 21 ( table  9 ) . By contrast, the urinary excretion of the dopamine precursor, L -Dopa, was increased in HgCl 2 -treated animals throughout the study ( table 9 ). This resulted in markedly reduced urinary dopamine/ L -Dopa ratios in HgCl 2 -treated rats throughout the study ( table 9 ) .
The tissue levels of norepinephrine were similar between HgCl 2 -treated and control rats on days 7, 14 and 21 after surgery ( table 5 ) . 
Discussion
The present study was undertaken with the aim of clarifying the possible role of the jejunal Na PAN is a toxic substance that induces a nephrotic syndrome without glomerular infl ammatory lesions or Ig deposits [23] , whereas HgCl 2 induces a systemic autoimmune disease that includes membranous nephropathy with IgG deposits [24] . These drug-induced nephropathies develop high-range proteinuria and full-blown nephrotic syndrome [14] . Because the time courses of urinary sodium excretion and the relationship between excretion of proteinuria and ascites differed in these two nephrotic syndrome rat models we performed a systematic study of the time courses of these parameters and evaluated the jejunal Na + ,K + -ATPase and dopaminergic activities in both PAN and HgCl 2 nephrosis in different temporal conditions including: (1) negligible proteinuria accompanied by signifi cant sodium retention (HgCl 2 nephrosis, day 7); (2) increased proteinuria accompanied by greatest sodium retention and ascites accumulation (PAN nephrosis, day 7; HgCl 2 nephrosis, day 14), and (3) increased proteinuria accompanied by enhanced renal sodium excretion and ascites mobilization (PAN nephrosis, day 14; HgCl 2 nephrosis, day 21).
Interestingly, we found in the two nephrotic syndrome rat models that in the presence of increased proteinuria, the jejunal Na + ,K + -ATPase activity was reduced during the phase of greatest sodium retention and positive sodium balance but not during enhanced sodium excretion and ascites mobilization. Because the driving force that energizes all mechanisms of jejunal sodium absorption is the hydrolysis of ATP catalyzed by Na + ,K + -ATPase located at the basolateral membrane of intestinal epithelial cells [25] , these fi ndings provide evidence for a decreased jejunal sodium absorption in the nephrotic syndrome when the extracellular volume is expanded due to abnormal renal sodium retention. Our results fi t well with the previous fi ndings suggesting that extracellular volume expansion with isotonic saline, 5% albumin or during ascitic cirrhosis may be accompanied by decreases in jejunal ion and fl uid absorption [26] [27] [28] [29] [30] [31] [32] . The fi nding of reduced Na + ,K + -ATPase activity in jejunal epithelial cells during greatest sodium retention in both nephrotic syndrome rat models, involving different toxic agents and different histologic types of glomerular lesions, suggests that the modulation of jejunal sodium absorption may take place in response to changes in sodium metabolism in other nephrotic syndrome conditions, including minimal change disease and membranous nephropathy in human patients.
The phase of sodium retention with negligible proteinuria was only observed in HgCl 2 -treated rats because in PAN nephrosis proteinuria was always profuse. We found in HgCl 2 -treated rats that the jejunal Na tivity on day 7 did not differ from controls. Given that in all experimental models of nephrotic syndrome, the expansion of extra-cellular volume and formation of ascites requires the association of proteinuria and marked decrease in urinary sodium excretion [14] , one can speculate that on day 7 the HgCl 2 -treated rats were not suffi ciently volume expanded to induce a jejunal response.
During the phase of increased renal sodium excretion and ascites mobilization, the jejunal Na + ,K + -ATPase activity was found to be signifi cantly increased in HgCl 2 -treated but not in PAN-treated rats. Because the HgCl 2 -treated rats exhibited a negative sodium balance going along with a decrease in body weight, one can hypothesize that the enhanced jejunal Na + ,K + -ATPase activity on day 21 may have resulted from the decrease in extracellular volume. In agreement with this view are the results showing that the decrease in extracellular volume following sodium depletion, dehydration and hemorrhage is associated with a substantial increase in the rate of ion and water absorption from small intestine [33] [34] [35] [36] . The fi nding that the jejunal Na + ,K + -ATPase activity on day 14 was similar between PAN-treated and control rats may be explained on the basis that the negative sodium balance in PAN-treated rats was not accompanied by a decrease in the extracellular volume. In agreement with this view is the similar body weight between PAN-treated and control rats as well as the presence of residual ascites in PAN-treated rats on day 14.
The use of drug-induced nephrotic syndrome rat models could be associated with direct toxicity of both PAN and Hg on jejunal epithelial cells as well as on Na + ,K + -ATPase activity. However, a previous study on the jejunal transport in PAN-induced nephrotic syndrome suggested that the decrease in the intestinal absorption of glucose, phenylalanine, histidine, water and sodium is not related to acute PAN toxicity being instead associated with the metabolic consequences of the nephrotic syndrome [37] . Although Hg is known to induce toxic effects in different body organs and cellular components including jejunal epithelial cells [38, 39] , limited or non existing data is available regarding the jejunal Na + ,K + -ATPase. In jejunum, Hg was associated with inhibition of amino acid and sugar transport [40] [41] [42] and the sites of Hg action were suggested to be located in the mucosal surface of jejunal slices but not in the basolateral cell border [43] . The results of the present study in HgCl 2 -treated rats showing that the jejunal Na [6, 12, 44] . Intestinal function has a great impact during early postnatal life, not only on the uptake of nutrients but also on the maintenance of electrolytes and water metabolism [45, 46] . In fact, although nephrogenesis is complete at birth, renal tubular function continues to develop postnatally, and the kidney has a limited capacity to regulate fl uids and electrolyte homeostasis [47] . The lack of effect of dopamine on jejunal Na + ,K + -ATPase activity in adult animal coincided with the period in which renal function has reached maturation [12, 44] . Recently, a reduction in jejunal Na + ,K + -ATPase activity with recovered sensitivity to inhibition by dopamine was reported in rats submitted to uninephrectomy presenting an enhanced dopamine synthesis per nephron [13] . This further suggested the occurrence of complementary functions between the intestine and the kidney with dopaminergic system playing a role in renal-intestinal cross-talk. In the present study, the jejunal AADC activity was not altered in both nephrotic syndrome rat models and the jejunal Na + ,K + -ATPase activity was not sensitive to inhibition by dopamine throughout the study. This was accompanied in both nephrotic syndrome rat models by a decreased renal dopamine synthesis as evidenced by a reduced urinary dopamine excretion accompanied by decreased urinary dopamine/ LDopa ratios throughout the study. Since the urinary dopamine/ L -Dopa ratios are used as rough measure of tubular uptake and/or decarboxylation of L -Dopa to dopamine, our fi ndings suggest that the decreases in urinary dopamine excretion observed in both nephrotic syndrome rat models are related to a reduced tubular uptake/ decarboxylation of L -Dopa to dopamine. In addition, the PAN-treated rats presented a decreased creatinine clearance suggesting that a reduced number of well functioning tubular units may also contribute to the decrease in urine dopamine excretion in PAN-treated but not in HgCl 2 -treated animals. Taken together, our results suggest that in either PAN-or HgCl 2 -induced nephrosis the observed changes in jejunal Na Since our results were negative in terms of the role of dopaminergic system in the jejunum, one can hypothesize that other mechanisms involved in sodium transport can account for the changes in jejunal Na + ,K + -ATPase in the nephrotic syndrome. The changes observed in jejunal Na + ,K + -ATPase in both nephrotic syndrome rat models could be infl uenced by blood pressure values. However, no signifi cant changes were observed in MAP in either PAN or HgCl 2 nephrosis. Norepinephrine is well-recognized to stimulate sodium transport by increasing the jejunal Na + ,K + -ATPase activity. However, the jejunal tissue levels of norepinephrine did not differ between the nephrotic and control rats throughout the study with the exception of PAN-treated rats on day 7 where a decreased jejunal Na + ,K + -ATPase activity was accompanied by increased jejunal tissue levels of norepinephrine. Thus one can conclude that, similarly to dopamine, jejunal norepinephrine cannot account for the observed changes in jejunal Na + ,K + -ATPase activity in both nephrotic syndrome rat models. Other mediator mechanisms can modulate the intestinal sodium transport in response to changes in extracellular volume and deserve further study in a state of proteinuria. Evidence has been gathered showing that ANP reduces fl uid absorption in response to acute volume expansion [29] , whereas both angiotensin II and angiotensin III can enhance intestinal electrolyte and fl uid absorption in response to volume depletion [35] . In addition, angiotensin II was shown to modulate the intestinal Na + ,K + -ATPase activity via calcium mobilization and PKC activation [48] . In acute renal failure, an increase in serum aldosterone was suggested to stimulate the jejunal Na It is concluded that in the nephrotic syndrome the jejunal Na + ,K + -ATPase activity appears to respond in a compensatory way to changes in extracellular volume by dopamine-independent mechanisms.
